Neo Ivy Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-482
| Closed | -$30K | – | 580 |
|
|
2022
Q3 | $30K | Sell |
482
-2,047
| -81% | -$127K | 0.08% | 268 |
|
|
2022
Q2 | $201K | Sell |
2,529
-2,733
| -52% | -$217K | 0.54% | 60 |
|
|
2022
Q1 | $554K | Buy |
5,262
+5,204
| +8,972% | +$548K | 0.5% | 55 |
|
|
2021
Q4 | $6K | Buy |
+58
| New | +$6K | 0.01% | 400 |
|
|
2021
Q2 | – | Sell |
-1,037
| Closed | -$95K | – | 666 |
|
|
2021
Q1 | $95K | Buy |
+1,037
| New | +$95K | 0.1% | 252 |
|
|
2020
Q4 | – | Sell |
-187
| Closed | -$14K | – | 634 |
|
|
2020
Q3 | $14K | Buy |
+187
| New | +$14K | 0.01% | 424 |
|
|
2020
Q2 | – | Sell |
-11,127
| Closed | -$330K | – | 657 |
|
|
2020
Q1 | $330K | Buy |
+11,127
| New | +$330K | 0.54% | 40 |
|
|
2019
Q2 | – | Sell |
-24,540
| Closed | -$648K | – | 455 |
|
|
2019
Q1 | $648K | Buy |
+24,540
| New | +$648K | 0.37% | 130 |
|